Articles From: Vodafone jumps; Fugro slides: Europe's big stock movers to JAKKS Pacific® and Meisheng Culture & Creative Corp Form Joint Venture to Bring JAKKS Products to China


By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Here are some companies whose shares are making notable moves in European trade on Tuesday.
Sign-up for Vodafone jumps; Fugro slides: Europe's big stock movers investment picks
Markit | Genpact KYC Services, the joint venture from Markit Ltd.
Sign-up for Markit | Genpact KYC Services Registers 600+ Firms and Appoints CEO investment picks
Trial expands the eligible patient population and overall NeuVax clinical trial portfolio Recent patent allowance provides intellectual property protection for NeuVax in combination with Herceptin in any HER2/neu expressing cancer PORTLAND, Ore., Nov.
Sign-up for Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Combination With Herceptin(R) (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breast Cancer Patients investment picks
2014/11/11
Study finds the median-income household could generate more than 50 percent more net wealth over the next 10 years by renting and investing instead of buying a home.
Sign-up for House of Cards: Morningstar's HelloWallet Unit Examines How Buying a Home vs. Renting and Investing Affects Wealth Creation investment picks
SAN DIEGO, Nov.
Sign-up for Conatus Pharmaceuticals to Present at Stifel 2014 Healthcare Conference investment picks
NEW YORK and BAGHDAD, Iraq, Nov.
Sign-up for Iraq Stock Exchange Launches Nasdaq's X-stream Trading Technology investment picks
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that data from the AKB-6548 development program will be presented in two poster sessions at the upcoming American Society of Nephrology (ASN) Kidney Week 2014 annual meeting in Philadelphia, PA from November 11-16, 2014.
Sign-up for Akebia Announces Poster Presentations at the Upcoming American Society of Nephrology Kidney Week 2014 Annual Meeting investment picks
2014/11/11
SHANGHAI , Nov.
Sign-up for Taomee Holdings Limited to Host Third Quarter 2014 Earnings Conference Call on Tuesday, November 25, 2014 investment picks
Demandware ®, Inc. (NYSE: DWRE), the industry-leading provider of enterprise cloud commerce solutions, today announced that the company will present at the following conference: UBS Global Technology Conference Tim Adams, Demandware Chief Financial Officer, will present on Thursday, November 20 th at 8:30 a.m. PST at Cavallo Point, The Lodge at the Golden Gate An audio webcast of the presentation will be available on Demandware’s investor relations website at http://investors.demandware.com .
Sign-up for Demandware Executive to Present at Upcoming Investor Conference investment picks
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the Stifel 2014 Healthcare Conference, November 18, 2014 at 1:50 p.m. EST at The New York Palace Hotel in New York City.
Sign-up for Concert Pharmaceuticals to Present at Stifel 2014 Healthcare Conference on November 18, 2014 investment picks
HOUSTON , Nov.
Sign-up for Hercules Offshore Announces Management Changes investment picks
AECOM Technology Corporation (NYSE:ACM), the world’s #1-ranked engineering design firm, reported fourth-quarter revenue of $2.6 billion and net service revenue 1 , of $1.3 billion.
Sign-up for AECOM reports fourth-quarter, full-year fiscal year 2014 results investment picks
2014/11/11
Company receives 'Big Data Competency' status and introduces enhanced solution for Amazon Redshift at AWS re:Invent in Las Vegas BURLINGTON, Massachusetts , November 11, 2014 /PRNewswire/ -- Attunity Ltd.
Sign-up for Attunity Expands Big Data Offering for Amazon Web Services (AWS) and Becomes APN Advanced Technology Partner investment picks
AES Eletropaulo markedly reduces call volume and lowers processing time for a fast ROI RA'ANANA, Israel , November 11, 2014 /PRNewswire/ -- NICE Systems (NASDAQ: NICE) today announced that AES Eletropaulo, a major power distributor in Brazil , has deployed NICE Real-Time Process Optimization in its contact center to improve operational efficiency, lower the number of repeat calls, and reduce average processing time.
Sign-up for Brazil's AES Eletropaulo Deploys NICE Real-Time Solutions to Significantly Improve Operational Efficiency investment picks
THE WOODLANDS, Texas, Nov.
Sign-up for LGI Homes, Inc. Reports Third Quarter and YTD 2014 Results investment picks
HOUSTON , Nov.
Sign-up for Main Street Announces New Portfolio Investment investment picks
Charles & Colvard, Ltd.
Sign-up for Charles & Colvard to Present at the Southwest IDEAS Investor Conference on November 19th in Dallas investment picks
2014/11/11
MEF GEN14 — Transition Networks , Inc., the fiber access technology expert, a wholly owned subsidiary of Communications Systems, Inc. (NASDAQ-GM: JCS), announced that it will be actively participating in the MEF GEN14 event being held November 17-20 in Washington D.C. MEF GEN14 is a global Ethernet networking event for industry professionals involved in all aspects of state-of-the-art innovations powered by Carrier Ethernet, SDN, NFV and optical networking.
Sign-up for Transition Networks to Present Key Carrier Ethernet Solution Innovations at MEF GEN14 Show in Washington DC investment picks
HOUSTON , Nov.
Sign-up for Rowan Companies Appoints New Chief Financial Officer investment picks
Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced financial results for the quarter ended September 30, 2014 and provided an update regarding its ongoing clinical programs.
Sign-up for Trevena Reports Third Quarter 2014 Financial Results and Provides a Corporate Update investment picks
Integration of Samsung's mobile innovations with the SAP Mobile Platform will help unlock new possibilities for developers and enterprise customers across key industries SEOUL, South Korea , and BERLIN , Nov.
Sign-up for Samsung and SAP Announce Plans to Collaborate and Deliver Innovative Enterprise Solutions on Mobile Devices and Wearables for Key Industries investment picks
ALBANY, N.Y., Nov.
Sign-up for AngioDynamics to Present at Upcoming Investor Conferences investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978263001&sourceType=1 http://www.ccnmatthews.com/logos/20051018-prometic.gif LAVAL, QUEBEC --
Sign-up for ProMetic's PBI-4050 Cleared to Commence Clinical Trials in Patients with Diabetic Kidney Disease investment picks
CAMBRIDGE, Mass., Nov.
Sign-up for SAGE Therapeutics Reports Third Quarter 2014 Results investment picks
Ophthotech Corporation (Nasdaq:OPHT) today provided a business update on the Company and announced financial results for the third quarter ended September 30, 2014.
Sign-up for Ophthotech Provides Business Update and Reports Third Quarter 2014 Financial Results investment picks
Leading U.S. toy and consumer products manufacturer, JAKKS Pacific, Inc. (NASDAQ: JAKK), and Chinese entertainment and cultural production industry group, Meisheng Culture & Creative Corp., Ltd, (Stock Code: 002699.SZ) entered into a joint venture for the purpose of providing certain JAKKS licensed and non-licensed toys and consumer products to agreed upon territories of the People’s Republic of China.
Sign-up for JAKKS Pacific® and Meisheng Culture & Creative Corp Form Joint Venture to Bring JAKKS Products to China investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Vodafone jumps; Fugro slides: Europe's big stock movers to JAKKS Pacific® and Meisheng Culture & Creative Corp Form Joint Venture to Bring JAKKS Products to China
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent